Coating composition curable by thio-michael addition

US2022282119A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2022282119-A1
Application numberUS-202017637495-A
CountryUS
Kind codeA1
Filing dateAug 24, 2020
Priority dateAug 29, 2019
Publication dateSep 8, 2022
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein are a curable coating composition including at least one Michael donor (A) having at least one thiol group, at least one Michael acceptor (B) and at least one specific catalyst (C), a method of using the curable coating composition as a clear coating in a process to prepare a multilayer coating and a multilayer coating obtained from said process. Also described herein is a kit-of-parts including at least two separate containers C1 and C2, where the specific catalyst (C) is contained in container C1 and/or C2. Finally, described herein is a method of using specific salts of carboxylic acids as catalyst in a reaction between a Michael donor (A) having at least one thiol group and a Michael acceptor (B).

First claim

Opening claim text (preview).

1 . A curable coating composition comprising: (i) at least one Michael donor (A) comprising at least one thiol group, (ii) at least one Michael acceptor (B) and (iii) at least one catalyst (C) according to the general formula (I) wherein R 1 , R 2 and R 3 are, independently from each other, selected from the group consisting of linear, branched or cyclic alkyl groups, aryl groups, and aralkyl groups, X is selected from the group consisting of alkali metals, bismuth, zinc, zirconium, and HN(R 4 ) 3 , R 4 is selected from the group consisting of C 1 -C 10 alkyl groups and C 1 -C 10 hydroxyalkyl groups and n is an integral number of 1 to 8. 2 . The curable coating composition according to claim 1 , wherein the composition comprises at least one Michael donor (A) of formula (III) wherein R 5 to R 8 are, independently from each other, selected from the group consisting of hydrogen, hydroxy, C 1 -C 10 alkylene groups, C 1 -C 10 thioalkylene groups, C 2 -C 10 hydroxy alkylene groups, C 2 -C 10 hydroxy thioalkylene groups, and residues *—O—C(O)—(CH 2 ) q —SH with the proviso that at least one of R 5 to R 8 contains a thiol group and q is an integral number of 1 to 10. 3 . The curable coating composition according to claim 2 , wherein R 5 to R 8 are, independently from each other, a residue *—O—C(O)—(CH 2 ) q —SH with q being an integral number of 2. 4 . The curable coating composition according to claim 1 , wherein the composition comprises the at least one Michael donor (A) in a total amount of 10 to 50% by weight, based on a total weight of the composition. 5 . The curable coating composition according to claim 1 , wherein the at least one Michael acceptor (B) is selected from the group consisting of aliphatic urethane (meth)acrylate polymers, acrylic polymers comprising (meth)acrylate groups, and mixtures thereof. 6 . The curable coating composition according to claim 1 , wherein the coating composition comprises the at least one Michael acceptor (B) in a total amount of 20 to 55% by weight, based on a total weight of the coating composition. 7 . The curable coating composition according to claim 1 , wherein the residues R 1 and R 2 in formula (I) are, independently from each other, selected from the group consisting of linear and branched C 3 -C 5 alkyl groups and residue R 3 is a methyl group, with the proviso that a sum of all carbon atoms of residues R 1 , R 2 and R 3 is 8 or wherein R 1 and R 2 in formula (I) are, independently from each other, selected from the group consisting of phenyl groups and residue R 3 is a C 1 -C 12 -alkyl group. 8 . The curable coating composition according to claim 1 , wherein X in formula (I) is selected from the group consisting of lithium, sodium, potassium, bismuth, zinc, zirconium, and HN(R 4 ) 3 with R 4 being *—(CH 2 ) 2 —OH. 9 . The curable coating composition according to claim 1 , wherein n in formula (I) is an integral number of 1 to 4. 10 . The curable coating composition according to claim 1 , wherein the coating composition comprises the at least one catalyst (C) of formula (I) in a total amount of 0.05 to 6% by weight based on a total weight of the coating composition. 11 . The curable coating composition according to claim 1 , wherein the composition comprises at least 2 different catalysts (C) of formula (I). 12 . A kit-of-parts, comprising at least two separate containers C1 and C2, wherein the container C1 contains at least one Michael donor (A) comprising at least one thiol group and at least one Michael acceptor (B) and the container C2 contains at least one catalyst (C), or the container C1 contains at least one Michael donor comprising at least one thiol group (A), the container C2 contains at least one Michael acceptor (B) and the catalyst (C) is contained in container C1 and/or container C2 wherein the catalyst (C) has the general formula (I) wherein R 1 , R 2 and R 3 are, independently from each other, selected from the group consisting of linear, branched or cyclic alkyl groups, aryl groups, and aralkyl groups, X is selected from the group consisting of alkali metals, bismuth, zinc, zirconium, and HN(R 4 ) 3 , R 4 is selected from the group consisting of C 1 -C 10 alkyl groups and C 1 -C 10 hydroxyalkyl groups and n is an integral number of 1 to 8. 13 . A process for producing a multilayer coating (MC) on a substrate (S), the process comprising: (1) optionally applying a composition (Z1) to the substrate (S) and subsequently curing the composition (Z1) to form a cured first coating layer (S1) on the substrate (S); (2) applying, directly to the cured first coating layer (S1) or the substrate (S), (a) an aqueous basecoat composition (bL2a) to form a basecoat layer (BL2a) or (b) at least two aqueous basecoat compositions (bL2-a) and (bL2-z) in direct sequence to form at least two basecoat layers (BL2-a) and (BL2-z) directly upon each other; (3) applying a coating composition (cc) according to claim 1 directly to the coating layer (BL2a) or (BL2-z) to form a clear coat layer (CL), and (4) jointly curing the basecoat layer (BL2a) and the clear coat layer (CL) or the at least two basecoat layers (BL2-a) and (BL2-z) and the clear coat layer (CL). 14 . A multilayer effect and/or color coating prepared according to the process of claim 13 . 15 . A method of using at least one compound (C) of formula (I), wherein R 1 , R 2 and R 3 are, independently, selected from the group consisting of linear, branched or cyclic alkyl groups, aryl groups, and aralkyl groups, X is selected from the group consisting of alkali metals, bismuth, zinc, zirconium, and HN(R 4 ) 3 , R 4 is selected from the group consisting of C 1 -C 10 alkyl groups and C 1 -C 10 hydroxyalkyl groups and n is an integral number of 1 to 8, the method comprising using the at least one compound (C) of formula (I) as a catalyst in a reaction between at least one Michael donor (A) comprising at least one thiol group and at least one Michael acceptor (B). 16 . A process for producing a multilayer coating (MC) on a substrate (S), the process comprising: (1) optionally applying a composition (Z1) to the substrate (S) and subsequently curing the composition (Z1) to form a cured first coating layer (S1) on the substrate (S); (2) applying, directly to the cured first coating layer (S1) or the substrate (S), (a) an aqueous basecoat composition (bL2a) to form a basecoat layer (BL2a) or (b) at least two aqueous basecoat compositions (bL2-a) and (bL2-z) in direct sequence to form at least two basecoat layers (BL2-a) and (BL2-z) directly upon each other; (3) applying a coating composition prepared from the kit-of-parts according to claim 12 directly to the coating layer (BL2a) or (BL2-z) to form a clear coat layer (CL), and (4) jointly curing the basecoat layer (BL2a) and the clear coat layer (CL) or the at least two basecoat layers (BL2-a) and (BL2-z) and the clear coat layer (CL). 17 . The curable co

Assignees

Inventors

Classifications

  • Pearl essence, e.g. coatings containing platelet-like pigments for pearl lustre · CPC title

  • achieved by multilayers · CPC title

  • all layers being cured or baked together · CPC title

  • Priming paints (C09D5/08 takes precedence) · CPC title

  • from mercapto compounds and unsaturated compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2022282119A1 cover?
Described herein are a curable coating composition including at least one Michael donor (A) having at least one thiol group, at least one Michael acceptor (B) and at least one specific catalyst (C), a method of using the curable coating composition as a clear coating in a process to prepare a multilayer coating and a multilayer coating obtained from said process. Also described herein is a kit-…
Who is the assignee on this patent?
Basf Coatings Gmbh
What technology area does this patent fall under?
Primary CPC classification C09D181/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).